Hepatocellular Carcinoma (Liver Cancer) Treatment - Chuck's Envita Review
Dissatisfied with his response to standard oncology treatments for liver cancer, Chuck decided to look for alternatives, expecting better results. “They tried embolization, [but it] didn't really take care of the situation,” said Charles “Chuck” Harding, referring to the outcome of standard Hepatocellular Carcinoma treatments. To improve his outcome, Chuck decided to travel from Maryland to Envita Medical Centers, a Center of Excellence in precision integrative oncology, located in Scottsdale, Arizona.
Disclaimer: Individual results will vary. Envita makes no guarantees for outcomes. Each patient case is unique. Please consult your doctor before making any changes to your medical treatment. Not every patient is a candidate for care or achieves these results. Treatments used in this case may not all be FDA approved for the treatment of this condition.
Impressed with the Personalized Precision Approach for Holistic Recovery
“My expectations were all exceeded, exponentially exceeded!” said Chuck, as he was not just impressed with the personal touch of the doctors and the staff, but the unique and personalized approach of treating the disease as well. At Envita, our team of physicians have been specially trained to custom develop treatment protocols for each individual patient, targeting the root causes of their disease, while strengthening their immune system for lasting outcomes. “You need to go to a place that not only has the faith but has the technology to follow up on their promises to you,” added Chuck, who has devoted his life to ministry.
Personalized Proprietary Treatments and Immunotherapy
Chuck experienced tremendous success with our proprietary treatments, such as GTFC™ (Genetically Targeted Fractionated Chemotherapy), which unlike standard maximum therapeutic dose untargeted chemotherapy, is based on a detailed genomic analysis and specialty tests. The results of these tests point to the most appropriate chemotherapy agents for targeting the patient's disease. This information enables our team of physicians to utilize metronomic dosage of a greater number of chemotherapy agents than in standard protocols, thus enhancing the mechanisms of action against the cancerous cells while minimizing impact to healthy cells.
Minimum impact to the healthy cells reduces the chances of severe side effects, typically associated with standard chemotherapy protocols. “This venture was not an endurance contest, it was very pleasant,” added Chuck, feeling extremely satisfied with his response to treatment at Envita. Along with GTFC™, every patient's protocol, like Chuck's, includes certain levels of advanced targeted immunotherapies, as our doctors understand that the immune system is the first and the last line of defense against cancer. This uniquely detailed and comprehensive approach is the backbone to paving the way for many such successful recoveries like Chuck's.
His Envita Connection
“The encouragement, that affirmation, the professionalism, the friendliness... has been so refreshing,” added Chuck, who felt his care at Envita was led by divine providence. He had first heard about Envita from a doctor, whose wife had a successful recovery at Envita, and the Texas-based couple were returning home from Envita when Chuck had called for guidance. Now, after completing care at Envita, Chuck feels grateful for following his calling as he looks forward to living a long and healthy life, accompanied by his loving wife!
Call Us Today
Envita's specially trained team includes oncologists, interventional radiologists, researchers, and pharmacists, who undergo over 1,500 hours of intensive training in the unique approach of personalized precision integrative oncology. Collaboratively, they create tailored treatment strategies to potentially improve the patient's quality of life, increase longevity, and reduce toxicities. For any inquiries regarding cancer, feel free to reach out to us at 866-830-4576.
